Intocef 250mg/125mg Injection
Marketer
Safe U Pharmaceuticals
Salt Composition
Ceftriaxone (250mg) + Sulbactam (125mg)
Overview Intocef 250mg/125mg Injection
Cefixime/Sulbactam 250mg/125mg injection is a dual-action antibiotic used to combat diverse bacterial infections. This medication inhibits bacterial proliferation, thereby curbing infection spread. Administration must be under a doctor's direct guidance; strict adherence to the prescribed schedule is crucial, completing the full course regardless of symptom improvement. Premature cessation can compromise treatment effectiveness. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate medical consultation. Seek immediate medical attention for allergic reactions (e.g., skin rashes, itching, swelling, respiratory distress). Prior to commencing treatment, inform your physician of all other medications and pre-existing health conditions. This includes disclosure for pregnant or lactating individuals. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, avoid operating vehicles if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and sufficient hydration contribute to optimal recovery. Your physician may order laboratory tests to monitor treatment efficacy.
Primary Ingredients of Intocef 250mg/125mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Intocef 250mg/125mg Injection
Infections caused by bacteria
Major Benefits of Intocef 250mg/125mg Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strictly prohibited.
Common Side effects of Intocef 250mg/125mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Intocef 250mg/125mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Intocef 250mg/125mg Injection works:
The injectable formulation, Intocef 250mg/125mg, unites Ceftriaxone, a bacterial growth inhibitor, with Sulbactam, a beta-lactamase inhibitor. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, crucial for bacterial viability. Sulbactam augments Ceftriaxone's effectiveness by counteracting bacterial resistance mechanisms.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Intocef 250mg/125mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
Cefazolin injection (250mg/125mg) is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harm to offspring; nevertheless, clinical data from human subjects are scarce.
Breast feedingCAUTION
Cefuroxime 250mg/125mg injection requires careful consideration during lactation. Mothers should discontinue breastfeeding throughout the course of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administration of Intocef 250mg/125mg Injection could induce drowsiness, visual disturbances, or dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Intocef 250mg/125mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The Intocef 250mg/125mg Injection requires careful administration for individuals with significant hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alterations for Intocef 250mg/125mg Injection are not suggested for patients experiencing mild or moderate liver dysfunction.
What if you forget to take Intocef 250mg/125mg Injection :
Should you forget a dose of Intocef 250mg/125mg Injection, seek medical advice.
Facts to Know About Intocef 250mg/125mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently